D. Boral Capital Reiterates “Buy” Rating for Coya Therapeutics (NASDAQ:COYA)
Coya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at D. Boral Capital in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $18.00 price target on the stock. D. Boral Capital’s target price would suggest a potential upside of 179.07% from the company’s previous […]
Coya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at D. Boral Capital in a research note issued to investors on Tuesday,Benzinga reports. They currently have a $18.00 price target on the stock. D. Boral Capital’s target price would suggest a potential upside of 179.07% from the company’s previous […]
